RetinalGenix Technologies (RetinalGenix Technologies) Market Cap : $62.51 Mil (As of Jun. 08, 2024)

View and export this data going back to 2022. Start your Free Trial

What is RetinalGenix Technologies Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). RetinalGenix Technologies's share price for the quarter that ended in Mar. 2024 was $3.5. RetinalGenix Technologies's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 17.86 Mil. Therefore, RetinalGenix Technologies's market cap for the quarter that ended in Mar. 2024 was $62.51 Mil.

RetinalGenix Technologies's quarterly market cap declined from Sep. 2023 ($78.97 Mil) to Dec. 2023 ($54.49 Mil) but then increased from Dec. 2023 ($54.49 Mil) to Mar. 2024 ($62.51 Mil).

RetinalGenix Technologies's annual market cap increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($155.45 Mil) but then declined from Dec. 2022 ($155.45 Mil) to Dec. 2023 ($54.49 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. RetinalGenix Technologies's Enterprise Value for Today is $62.51 Mil.

RetinalGenix Technologies Market Cap Historical Data

The historical data trend for RetinalGenix Technologies's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RetinalGenix Technologies Market Cap Chart

RetinalGenix Technologies Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Market Cap

155.45

54.49

RetinalGenix Technologies Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Market Cap	Get a 7-Day Free Trial										155.45	155.45	78.97	54.49	62.51

Competitive Comparison of RetinalGenix Technologies's Market Cap

For the Medical Devices subindustry, RetinalGenix Technologies's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RetinalGenix Technologies's Market Cap Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, RetinalGenix Technologies's Market Cap distribution charts can be found below:

* The bar in red indicates where RetinalGenix Technologies's Market Cap falls into.

RetinalGenix Technologies Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

RetinalGenix Technologies's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	$3.09	*	17.6355
	=	$54.49

RetinalGenix Technologies's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )	=	Share Price (Q: Mar. 2024 )	*	Shares Outstanding (EOP) (Q: Mar. 2024 )
	=	$3.5	*	17.8605
	=	$62.51

RetinalGenix Technologies (OTCPK:RTGN) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

RetinalGenix Technologies Market Cap Related Terms

Thank you for viewing the detailed overview of RetinalGenix Technologies's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

RetinalGenix Technologies (RetinalGenix Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » RetinalGenix Technologies Inc (OTCPK:RTGN) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

1450 North McDowell Boulevard, Suite 150, Petaluma, CA, USA, 94954

Website

https://www.retinalgenix.com

RetinalGenix Technologies Inc is an ophthalmic research and development company focused on developing technologies to screen, monitor, diagnose, and treat ocular, optical, and sight-threatening disorders, Its mission is to prevent vision loss and blindness due to diabetic retinopathy and maculopathy through early detection from the use of two devices: (1) Retinal Imaging Screening Device (RetinalGenixTM), being designed as a portable, high-resolution retinal imaging Diabetic screening system providing a 200-degree field of view without requiring pupil dilation; and (2) RetinalCamTM, being designed as a high-resolution home monitoring retinal imaging device and physician alert system offering real-time communication with physicians available 24/7.